Chemical Control of a CRISPR-Cas9 Acetyltransferase

Citations Over TimeTop 17% of 2018 papers

Abstract

Lysine acetyltransferases (KATs) play a critical role in the regulation of transcription and other genomic functions. However, a persistent challenge is the development of assays capable of defining KAT activity directly in living cells. Toward this goal, here we report the application of a previously reported dCas9-p300 fusion as a transcriptional reporter of KAT activity. First, we benchmark the activity of dCas9-p300 relative to other dCas9-based transcriptional activators and demonstrate its compatibility with second generation short guide RNA architectures. Next, we repurpose this technology to rapidly identify small molecule inhibitors of acetylation-dependent gene expression. These studies validate a recently reported p300 inhibitor chemotype and reveal a role for p300s bromodomain in dCas9-p300-mediated transcriptional activation. Comparison with other CRISPR-Cas9 transcriptional activators highlights the inherent ligand tunable nature of dCas9-p300 fusions, suggesting new opportunities for orthogonal gene expression control. Overall, our studies highlight dCas9-p300 as a powerful tool for studying gene expression mechanisms in which acetylation plays a causal role and provide a foundation for future applications requiring spatiotemporal control over acetylation at specific genomic loci.

Related Papers

• → Non-viral and viral delivery systems for CRISPR-Cas9 technology in the biomedical field(2017)52 cited
• → Cas9 Cuts and Consequences; Detecting, Predicting, and Mitigating CRISPR/Cas9 On‐ and Off‐Target Damage(2020)20 cited
• → [Research progress of CRISPR-Cas9 system for gene therapy].(2016)6 cited
• Effect of N~α-Terminal Acetyltransferase RimI on Human Prothymosin α Acetylation Expressed in Escherichia coli(2011)
• → Prediction of off-target effects of the CRISPR/Cas9 system for design of sgRNA(2020)